Recent evidence indicates that AKT is frequently activated in many types of human cancer, and activated PI3K/AKT/mTOR signaling pathway is a significant contributor to tumor progression and poor prognosis, including bladder cancer [35]. This evidence concerns the gene MTOR and urinary bladder cancer.